ArticleScience translational medicine2023

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.

Minsoo Khang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.